Dr Scott J Turner | Specialist Plastic Surgeon (FRACS) | Sydney
A few years ago, this conversation was on the fringes. Patients who’d had years of dermal fillers and were starting to wonder whether something had gone wrong. Surgeons quietly noting in operating theatres that the tissue planes didn’t feel quite right. Academic papers trickling out with concerning findings about how long these “temporary” products actually persist in tissue.
That’s not the fringe anymore. The conversation has moved into mainstream media, into the consultation room, and onto the desks of plastic surgeons internationally. I’m Dr Scott J Turner, a Specialist Plastic Surgeon (FRACS) practising at my Sydney clinics in Bondi Junction and Manly. This article is the broad picture I share with patients when the topic of dermal fillers and future surgery comes up. The detailed technical pieces sit elsewhere in this cluster, and I’ll point to them as we go.
The Cultural Moment: Why This Conversation Has Changed
Three things shifted at roughly the same time, and the combined effect is significant.
First, social media changed who controls the narrative. For years, the public message about dermal fillers was largely shaped by the cosmetic industry. Six to twelve months. Reversible. Subtle. Then patients started talking publicly about their own experiences. Influencers documenting filler removal. Public figures discussing dissolving years of injectables. Beauty journalists writing pieces with titles like “the quiet shift away from filler.” That conversation happened on platforms where the cosmetic industry doesn’t have editorial control, and the picture that emerged was more complicated than the marketing suggested.
Second, academic research caught up. MRI imaging studies began tracking what actually happens to hyaluronic acid filler over time, and what they found contradicted the standard 6-to-12-month claim by years. Surgeon survey data documented a measurable increase in operative difficulty when patients had extensive filler histories. Case reports of granulomas, biofilm infections, and vascular complications associated with long-term filler use began appearing more frequently in peer-reviewed plastic surgery journals.
Third, a generation of patients hit the maths. People who started fillers in their twenties were now in their thirties and forties, looking at the cumulative anatomical and financial picture, and starting to wonder whether the maintenance pattern still made sense. Many of these are the patients sitting in my consultation room now.
What the Academic Research Is Actually Showing
I want to be careful here. Research is research. It’s not a verdict. But the findings of the past few years are substantial enough that any honest conversation about dermal fillers and future surgery has to engage with them.
Persistence beyond what was originally claimed. MRI studies tracking patients who’d had hyaluronic acid filler treatments years earlier consistently showed that material was still present in tissue, often well beyond the 6-to-12-month timeframe patients had been told to expect. In some cases, filler was visible on imaging more than a decade after the original injection. Our filler migration and retention guide covers the specific imaging evidence in detail.
Migration from the original injection site. Once placed, filler doesn’t always stay where it was put. Movement of facial muscles, gravity, and the natural movement of facial soft tissue over time means product can travel. That migration is often subtle and gradual. The patient may not notice it, and neither does the injector at routine follow-up. But by the time a surgeon is dissecting the same anatomical region, the product has often dispersed across territory it was never intended to occupy.
Tissue distortion that’s measurable in surgery. Survey data from facial plastic surgeons internationally has documented that more than half (51.9% in one widely cited survey) report increased operative difficulty when working on patients with extensive filler histories. The tissue planes don’t behave the way they should. Surgical landmarks that are normally reliable become obscured. Roughly 15% of surgeons in the same survey reported compromised blood supply to facial flaps in patients with extensive filler histories, a more concerning finding because flap vascularity is fundamental to safe facelift surgery.
Inflammatory and infective complications years after treatment. Granulomas (inflammatory nodules the body forms around filler material) can develop months or years after the original injection. Biofilm infections, delayed bacterial colonisation around filler particles, can also appear long after the treatment is forgotten by both patient and injector. These complications are uncommon as a percentage of total filler treatments performed, but they are well-documented in the literature, and surgeons see them in operating theatres often enough that they are part of standard pre-surgical assessment now.
Chronic malar oedema and lymphatic congestion. A more recently recognised pattern is persistent puffiness in the mid-face and under-eye region after recurrent filler treatments in those areas. The current thinking is that repeated injections may interfere with normal lymphatic drainage in tissue planes that don’t tolerate that interference well. The result for the patient is a face that looks chronically a bit swollen, particularly in the morning, even when no recent treatment has been performed. This is one of the patterns that’s often misread as “needing more filler” when the underlying issue is the cumulative effect of previous filler.
None of this means dermal fillers are inherently dangerous. It means the picture is more complex than the original marketing suggested, and that “temporary” is not the right framing for a product that may persist in tissue for years.
Why Patients Are Talking About This More
Three patterns I see consistently in consultation:
The maintenance treadmill stops feeling worth it. A patient who started fillers at twenty-eight and is now thirty-eight has typically had thirty to sixty syringes of product placed over a decade. At Australian pricing of roughly $700 to $1,200 per syringe, that’s a cumulative spend somewhere between $20,000 and $60,000 across ten years, often more once other cosmetic injectable treatments and skin-quality treatments are added in. The financial picture is substantial. So is the time. And the anatomical effect, viewed cumulatively, doesn’t always look like what the patient was working toward. Faces look heavier than they used to. The jawline that filler was meant to define has, in many cases, become less defined. The patient feels the maths has stopped working. I want to be clear: this comparison isn’t to suggest surgery is “cheaper” than fillers. Surgery is a different category of investment. But for patients who’ve already spent a decade on the maintenance treadmill, looking at the next decade’s projected spend often shifts the calculation.
The mirror starts to show something unfamiliar. Patients describe looking at recent photos and not quite recognising themselves. The face has changed in ways that don’t match how the patient sees themselves internally. This is often the catalyst for the first surgical consultation.
The “pillow face” conversation. The cultural awareness of overfilling has moved into the patient’s own self-assessment. Once patients know what to look for, they start seeing it. The cheeks that look round rather than sculpted. The lip volume that has crept above the upper lip line. The general puffiness that wasn’t there ten years ago. The new 30s and 40s definitive guide covers this conversation and the surgical-decision pathway in depth.
What This Means for Future Facelift Surgery
For me as a surgeon, a patient with a long filler history changes how I plan a facelift in several specific ways.
Pre-operative imaging becomes more important. When I can’t reliably predict where filler has migrated to, I sometimes need additional imaging to map what’s actually there before I go to surgery.
Operative time may need to be longer. Working around dispersed filler material, removing granulomas if I find them, dealing with tissue tethering from old scarring, all of this takes more time than a standard facelift would.
Technique selection may be constrained. Some surgical approaches that would otherwise be ideal become less appropriate when there’s significant filler material in the planes I’d normally work in. This sometimes means a different technique than the one a patient might have read about and arrived expecting.
The dissolution conversation becomes part of pre-surgical planning. Most patients with significant filler history need at least some product dissolved before surgery, often in stages, with time to settle in between. Hyaluronidase has its own potential complications, and the planning is genuinely important. Our repeated fillers and hyaluronidase guide covers this in detail.
Consent conversations become more detailed. Patients with extensive filler histories need to understand that the surgery may take longer, recovery may be slightly more complex, and the result may be less predictable than it would be for a patient with no prior treatments. None of this is a deal-breaker. It just needs to be on the table before surgery is booked.
So, Do Fillers Ruin Facelifts?
Not in any literal sense. Patients with extensive filler histories can still have excellent facelift results. The honest answer is more measured: long-term, heavy filler use can make surgery technically more involved, may require pre-surgical dissolution and waiting periods, and can constrain technique selection in some cases. The result is still likely to be a meaningful improvement on the patient’s pre-surgical state. But it is fair to say that planning a facelift on a patient with a long filler history is a different exercise than planning one on a patient with no prior treatments.
The framing I find most useful with patients: filler doesn’t ruin facelifts, but it does shape them. The scope of what’s possible, the technique I select, the operative time, the recovery, and the consent conversation, all of these are influenced by what’s already been placed in the tissue. None of which is a reason to panic if you’ve had years of treatment. It is a reason to have the conversation properly, with full disclosure, well before surgery is booked.
When I Recommend Dissolving Filler, and When I Don’t
This is a question patients ask in almost every consultation involving a filler history. The answer is genuinely individual.
When dissolution before surgery usually makes sense:
- Visible filler migration that’s distorting facial proportions
- Significant overfilling in the mid-face creating a “pillow face” appearance
- Lip filler that has crept above the natural lip line or distorted the lip shape
- Unclear baseline anatomy, where I can’t reliably assess what your face actually looks like under the product
- Heavy lower-face or jawline filler that’s creating pseudo-ptosis (the appearance of tissue descent caused by the weight of accumulated product)
- Patient preference, where you want to see what you actually look like before committing to surgery
When dissolution may not be necessary or appropriate:
- Small amounts of filler that aren’t materially affecting tissue planes
- Old filler that’s stable and not causing distortion
- Cases where dissolving would create unnecessary inflammation close to the planned surgery date
- Patients with insect venom allergies, who are at higher risk of hyaluronidase reactions
- Non-hyaluronic acid fillers (calcium hydroxylapatite, poly-L-lactic acid) that hyaluronidase doesn’t dissolve
When dissolution is appropriate, it’s usually staged. One area at a time. Time between sessions to let tissues settle. Photographic and clinical reassessment between stages. Then a further waiting period (often three to six months) before surgical planning is finalised. Rushing this process is a recognised cause of suboptimal results and post-hyaluronidase syndrome, where tissues end up more hollow than the patient started. Our repeated fillers and hyaluronidase guide covers the dissolution process in clinical detail.
What AHPRA’s New Rules Mean for You as a Patient
In September 2025, AHPRA introduced significant new guidelines for non-surgical cosmetic procedures, including dermal fillers. These rules apply to the practitioners who provide your injectable treatments, and they’re worth understanding because they materially change what you should expect from any clinic offering these services.
The key elements that affect you directly as a patient:
Mandatory in-person or video consultation each time a prescription-only injectable is prescribed. This is significant. Asynchronous prescribing (a doctor approving a script via text, email, or an online tick-box without actually consulting you) is no longer acceptable practice. Every new prescription requires a real-time consultation with the prescribing doctor.
Stricter assessment of patient suitability and motivations. Practitioners are now expected to discuss your reasons and motivations for requesting treatment, screen for psychological factors including body dysmorphic disorder, and refer for independent assessment if there are concerns.
Discussion of alternatives, including surgery, where appropriate. This is a meaningful change. Patients are now meant to be told about the full range of options, including what surgery can and can’t address, rather than being defaulted into more injectable treatment.
Stricter advertising rules. Testimonials from social media influencers about cosmetic treatment outcomes are banned. Before-and-after images of under-18s are banned. Advertising aimed at people under 18 is banned. Higher-risk treatments must be classified as adult content on social media.
Mandatory complaint information. Before any cosmetic procedure, you must be told how to lodge a complaint with AHPRA, and any non-disclosure agreement you sign cannot prevent you from doing so.
Cooling-off period for under-18s. A mandatory seven-day period between first consultation and procedure for patients under eighteen.
What this means practically: if you’re considering ongoing dermal filler treatment, you have more protections now than you did before September 2025. If your current injector isn’t following these requirements (no proper consultation each time, no discussion of alternatives, no clear complaint pathway), that’s a signal worth paying attention to. The AHPRA framework is now the floor, not the ceiling, for what you should expect.
I’m a Specialist Plastic Surgeon, not a cosmetic injector, so these specific guidelines apply to my practice differently. But the principles behind them, informed consent, proper consultation, transparent discussion of alternatives, and patient safety taking priority over commercial considerations, are exactly the principles I apply to surgical consultation. When I’m assessing a patient with a long filler history, the question of whether their previous treatments were provided in line with these standards is part of the broader picture.
A Note on Other Non-Surgical Treatments
This article is specifically about dermal fillers because that’s the largest category of pre-surgical concern in current clinical practice. But it’s worth acknowledging briefly that dermal fillers aren’t the only non-surgical treatment that can affect future surgical planning.
Thread lifts leave material behind. Biostimulators (calcium hydroxylapatite, poly-L-lactic acid) trigger collagen changes that alter tissue behaviour during surgery. Aggressive HIFU and energy-based devices can scar the SMAS layer. RF microneedling, when used aggressively over time, can affect skin quality in ways that influence surgical planning.
Each of these deserves its own dedicated discussion, and a separate article on non-filler treatments is in development. For now, the practical point is the same: full disclosure of every prior treatment matters when surgery is being planned. Nobody is judging your treatment history. The information is needed so the surgical approach can account for what’s already been done to the tissue.
What an Honest Pre-Filler Conversation Should Cover
If you’re considering dermal filler treatment now (rather than reviewing a long history of it), here are the things any honest injector should be discussing with you, both as a matter of good practice and as a matter of AHPRA compliance:
- A proper in-person or video consultation each time a prescription injectable is being considered (not a ticked online box)
- Realistic persistence timeline based on current research, not the original marketing claims
- What dissolution actually involves if you ever want to remove the product
- How filler may affect your future surgical options
- What the cumulative cost looks like over five and ten years
- Whether your underlying concern is genuinely a volume problem (which filler can address) or a structural problem (which filler can’t)
- The patterns of overuse to watch for as treatments accumulate
- Clear information on how to make a complaint if you’re unhappy with treatment
Most cosmetic injectable practitioners are conscientious people doing their best for their patients. The conversation has shifted in recent years and many injectors are now having these discussions proactively. If your injector isn’t, that’s a signal worth paying attention to. The AHPRA framework now requires it.
A Practical Note for Patients Already in This Conversation
If you’ve been having dermal fillers for years and the maintenance pattern has stopped feeling sustainable, the next step isn’t necessarily surgery. It’s a careful clinical assessment of where you actually are, what’s happening anatomically, and what the realistic options look like for you specifically.
For some patients, the answer is to continue with judicious filler use and think about surgery later. For others, it’s to stop fillers, allow tissues to settle, and reassess in six to twelve months. For others still, the structural changes have already reached a point where surgery is the more appropriate next step. None of these is a default answer. Each is a clinical conclusion that comes out of consultation.
For the broader picture on the surgical-decision pathway in this age bracket, our 30s and 40s definitive guide covers the practical considerations from first consultation through full recovery.
Frequently Asked Questions
Are dermal fillers actually unsafe?
No, not as a category. Dermal fillers are widely used, generally well-tolerated, and produce results most patients are pleased with in the short term. The concerns I raise in this article are about cumulative effects over years of repeated treatments, the gap between marketed persistence and actual persistence shown in MRI studies, and the implications for future surgery. These are real concerns worth understanding. They are not a reason to panic about a single treatment or two.
How long do dermal fillers actually last?
Longer than the original 6 to 12 months commonly quoted by manufacturers. MRI imaging studies have shown hyaluronic acid filler persisting in tissue for years after injection, in some cases more than a decade. The product breaks down gradually rather than disappearing on a schedule. This is one of the more significant findings of the recent research and is covered in detail in our filler migration and retention guide.
Will my filler history affect what facelift techniques are available to me?
It can. Significant filler in the tissue planes I’d normally work in may make some techniques less appropriate than they would otherwise be. It often means longer operative time, more careful pre-surgical planning, and sometimes the need to dissolve product before surgery is scheduled. None of this rules out surgery for patients with filler histories. It just makes the planning more involved.
Should I dissolve all my fillers before considering surgery?
In many cases yes, but not without careful planning. Hyaluronidase has its own potential complications, including post-hyaluronidase syndrome where tissue ends up more hollow than before treatment started. The dissolution process is often staged, with time between sessions and time to settle before surgical planning is finalised. The full picture is covered in our repeated fillers and hyaluronidase guide.
Is this article saying I should stop having dermal fillers?
No. It’s saying the conversation has changed, the research has moved on from the original marketing claims, and patients deserve a more complete picture than they were sometimes given in the past. Whether dermal fillers continue to make sense for you depends on your individual situation, your goals, your treatment history to date, and what alternatives might be more appropriate for your specific concerns. That’s a clinical conversation, not a generic recommendation.
Consult with Dr Scott J Turner
If you’ve been having dermal fillers for years and are starting to wonder whether the maintenance pattern is still working for you, the first step is a careful clinical assessment. As a Specialist Plastic Surgeon (FRACS), my consultations cover assessment of your facial anatomy, discussion of your filler history, what dissolution may involve if appropriate, and an honest conversation about whether surgical or non-surgical options would better address what you’re trying to achieve.
In Australia, all cosmetic surgery requires a GP referral, a minimum of two consultations, psychological evaluation if appropriate, and a cooling-off period before surgery is scheduled. This regulatory process is in place to ensure decisions are made carefully and with full information.
Consultations are available at my Bondi Junction and Manly clinics. Call the practice on (02) 9387 3900 or email [email protected] to arrange an appointment.
Disclaimer: This article is for general information only. It does not constitute medical advice and is not a substitute for an in-person consultation. All cosmetic surgery carries risks. Individual results vary. Specialist Plastic Surgeon FRACS (2013), AHPRA MED0001654827.
